3T Event: UQ Vaccine - how we produced a vaccine in 12 weeks, why we stopped and what is the new UQ Vaccine? (in person)

In 2019, UQ received seed funding from the Coalition of Epidemic Preparedness Innovations (CEPI) to establish a rapid response vaccine pipeline, based on the “molecular clamp" technology.

 

When the pandemic hit in January 2020, the UQ team worked alongside CEPI and a team of Australian and International collaborators to shift its molecular clamp rapid response program to develop a vaccine candidate for COVID-19.

 

While the vaccine candidate ultimately did not progress through to Phase 2/3 clinical trials, it was shown to be safe and effective for future viruses.

 

Join us at The Women's College for morning tea and presentation from Professor Trent Munro, Senior Group Leader at the Australian Institute of Bioengineering and Nanotechnology, where we will venture behind the scenes of UQ’s COVID-19 vaccine project, including what's next for the team.

 

 

Paul Young is Professor of Virology and Head of the School of Chemistry & Molecular Biosciences at The University of Queensland, Brisbane, Australia. He gained his PhD from the London School of Hygiene & Tropical Medicine and joined the University of Queensland in 1991. His research aims to understand the molecular basis of virus induced disease, develop new and improved diagnostics as well as vaccine and therapeutic control strategies for a number of viral pathogens of both human and animal origin. Prof Young is Chair of the Virology Division of the International Union of Microbiological Societies and has been the President of the Australian Society for Microbiology (2012-2014), the Australasian Virology Society (2001-2011) and the Asia-Pacific Society for Medical Virology (2012-2015).